Bio Spectrum - December 2022![Legg til i Mine favoritter Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Bio Spectrum - December 2022![Legg til i Mine favoritter Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Få ubegrenset med Magzter GOLD
Les Bio Spectrum og 9,000+ andre magasiner og aviser med bare ett abonnement Se katalog
1 Måned $9.99
1 År$99.99
$8/måned
Abonner kun på Bio Spectrum
1 år$11.88 $7.99
Kjøp denne utgaven $0.99
I denne utgaven
Can INDIA Dethrone CHINA In API PRODUCTION?
The past decade has witnessed a steady growth and commitment of the Indian government in addressing issues like ‘self-reliance and self-sufficiency’ in all aspects of governance and decisions. While sops and subsidies were, indeed, crucial to many concerns of industries and stakeholders, key decisions and schemes were lacking, until numerous ‘Aatmanirbhar Projects’ were kicked off by the Centre. One such crucial initiative addresses the need for Bulk Drugs Parks in India, making the country less dependent on Chinese Active Pharmaceutical Ingredients (APIs), providing more employment and generating more revenue that will add to the country’s GDP. A laudable step has been taken with the launching of three Bulk Drugs projects across three states in the country, with an estimated time of completion set at 5 years. We shall take a closer look at what the project entails and seek expert views from a few industry stalwarts.
Bio Spectrum Magazine Description:
Utgiver: MM Activ Sci-Tech Communication
Kategori: Business
Språk: English
Frekvens: Monthly
India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.
Kanseller når som helst [ Ingen binding ]
Kun digitalt